Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications

Abstract.Objective:To objectively quantify stiffness and clinical changes in the upper limb of poststroke patients following botulinum toxin (BT) injection.Methods:Eighteen consecutive chronic post-stroke spastic patients were injected Botulinum toxin A in the forearm flexor spastic muscles. Spasticity was clinically evaluated with the Ashworth scale. Stiffness was measured with indices (passive stiffness index (ISI) and total stiffness index (TSI) obtained by mechanical wrist displacements induced by a torque motor,which could also provide the stretch reflex threshold speed (SRTS) from flexor muscles. Functional status was measured with the Barthel index and a specific hand ability scale, pain with a visual analogue scale (VAS). The ranges of voluntary wrist extension (EROM) and flexion (FROM) and wrist isometric extension and flexion (IE—IF) strength were also calculated.Results:IE and EROM significantly increased, being respectively p < 0.01 and p < 0.05; also SRTS was augmented (p < 0.001),while TSI showed lower values (p < 0.001); the Ashworth score decreased at least one point.Hand function for selected tasks improved in 50% of patients, the Barthel index only in 4 (22 %), forearm pain was completely relieved in 3 patients (17 %).Conclusions:BT can be considered a valid therapeutic tool in all spastic patients, because of immediate advantages: reduction of muscle hypertonia, pain relief, improvement in selected motor performances.

[1]  P. Errico,et al.  Effect of botulinum toxin on extraocular muscle proprioception , 1989, Documenta Ophthalmologica.

[2]  Lin Fumei,et al.  Correlation of Spasticity With Hyperactive Stretch Reflexes and Motor Dysfunction in Hemiplegia , 1999 .

[3]  L. Simpson.  The origin, structure, and pharmacological activity of botulinum toxin. , 1981, Pharmacological reviews.

[4]  W. Tatton,et al.  Dependence of EMG Responses Evoked by Imposed Wrist Displacements on Pre-existing Activity in the Stretched Muscles , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[5]  J Quintern,et al.  Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia. , 1981, Brain : a journal of neurology.

[6]  H. Wellhöner,et al.  The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex , 1977, Naunyn-Schmiedeberg's Archives of Pharmacology.

[7]  L. Gutmann,et al.  Pathophysiologic aspects of human botulism. , 1976, Archives of neurology.

[8]  Werner Poewe,et al.  A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Compare the Efficacy and Safety of Three Doses of Botulinum Toxin Type A (Dysport) With Placebo in Upper Limb Spasticity After Stroke , 2000, Stroke.

[9]  A. Suputtitada.  Local Botulinum Toxin Type A Injections in the Treatment of Spastic Toes , 2002, American journal of physical medicine & rehabilitation.

[10]  M. Sabbahi,et al.  Correlation of spasticity with hyperactive stretch reflexes and motor dysfunction in hemiplegia. , 1999, Archives of physical medicine and rehabilitation.

[11]  Lewis P Rowland.  Stroke, spasticity, and botulinum toxin. , 2002, The New England journal of medicine.

[12]  S. Otto,et al.  A randomized, double‐blind, placebo‐controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke , 2001, European journal of neurology.

[13]  Wen-Chou Chi,et al.  Effect of Intramuscular Botulinum Toxin Injection on Upper Limb Spasticity in Stroke Patients , 2002, American journal of physical medicine & rehabilitation.

[14]  R. Chan,et al.  Effect of Botulinum Toxin Type A on Cerebral Palsy with Upper Limb Spasticity , 2003, American journal of physical medicine & rehabilitation.

[15]  T. Carey.  Functional outcome of botulinum toxin A injections to the lower limbs in cerebral palsy, , 2003, Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association.

[16]  D. M. Simpson,et al.  Botulinum toxin type A in the treatment of upper extremity spasticity , 1996, Neurology.

[17]  N. Hyman,et al.  Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study , 2000, Journal of neurology, neurosurgery, and psychiatry.

[18]  Fabrizio Pisano,et al.  Quantitative measures of spasticity in post-stroke patients , 2000, Clinical Neurophysiology.

[19]  J. Nilsson,et al.  Functional and clinical changes in upper limb spastic patients treated with botulinum toxin (BTX). , 2000, Functional neurology.

[20]  S. Smith,et al.  A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury , 2000, Clinical rehabilitation.

[21]  Richard W. Bohannon,et al.  Interrater reliability of a modified Ashworth scale of muscle spasticity. , 1987, Physical therapy.

[22]  M. Barnes,et al.  Botulinum toxin and spasticity , 2000, Journal of neurology, neurosurgery, and psychiatry.

[23]  M. Brin,et al.  BOTULINUM TOXIN FOR TREATMENT OF SPASTICITY IN MULTIPLE SCLEROSIS , 1992 .

[24]  J. Comella,et al.  Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type a toxin: Morphological and electrophysiological features , 1990, Neuroscience.

[25]  D. Tarsy,et al.  Botulinum toxin A in the treatment of spasticity: functional implications and patient selection. , 1996, Archives of physical medicine and rehabilitation.

[26]  Rajesh Balkrishnan,et al.  Spasticity Associated with Cerebral Palsy in Children , 2003, Paediatric drugs.

[27]  H. Hjaltason,et al.  A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport® and Botox®in the treatment of cervical dystonia , 1998, Journal of neurology, neurosurgery, and psychiatry.

[28]  K. Aló,et al.  Botulinum toxin in the treatment of myofascial pain , 1997 .

[29]  F. Colle,et al.  Disabling overactivity of the extensor hallucis longus after stroke: clinical expression and efficacy of botulinum toxin type A. , 2003, Archives of physical medicine and rehabilitation.

[30]  F. Mahoney,et al.  Functional evaluation ; the Barthel index. A simple index of the independence useful in scoring improvement in the rehabilitation of the chronically ill. , 1965 .

[31]  B. Bioulac,et al.  A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[32]  D B Calne,et al.  Treatment of spasticity with botulinum toxin: A double‐blind study , 1990, Annals of neurology.

[33]  J. Tobis,et al.  Contractures in chronic neurologic disease. , 1957, Archives of physical medicine and rehabilitation.

[34]  R L Hewer,et al.  Functional abilities after stroke: measurement, natural history and prognosis , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[35]  A. Berardelli,et al.  Botulinum toxin restores presynaptic inhibition of group Ia afferents in patients with essential tremor , 1998, Muscle & nerve.

[36]  C. Chapman,et al.  Pain measurement: an overview , 1985, Pain.

[37]  Fabrizio Pisano,et al.  Quantitative evaluation of normal muscle tone , 1996, Journal of the Neurological Sciences.

[38]  P. Errico,et al.  Botulinum A toxin effects on rat jaw muscle spindles. , 1993, Acta oto-laryngologica.

[39]  J. Comella,et al.  Sprouting of mammalian motor nerve terminals induced by in vivo injection of botulinum type-D toxin and the functional recovery of paralysed neuromuscular junctions , 1993, Neuroscience Letters.

[40]  E. Elovic,et al.  Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. , 2002, The New England journal of medicine.

[41]  B. Bhakta,et al.  Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial , 2000, Journal of neurology, neurosurgery, and psychiatry.

[42]  C. Boake,et al.  Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury , 1996, Neurology.

[43]  A. Berardelli,et al.  Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. , 1995, Brain : a journal of neurology.

[44]  P. Flett.  Rehabilitation of spasticity and related problems in childhood cerebral palsy , 2003, Journal of paediatrics and child health.

[45]  M. Brin,et al.  BOTULINUM TOXIN FOR THE TREATMENT OF SPASTICITY IN MULTIPLE SCLEROSIS: New Observations , 1993, American journal of physical medicine & rehabilitation.

[46]  Michael P Barnes,et al.  Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox® to the elbow flexors in a unilateral stroke population , 2002, Clinical rehabilitation.

[47]  R. Dengler,et al.  Local botulinum toxin in the treatment of spastic drop foot , 1992, Journal of Neurology.

[48]  H. Topka,et al.  Management of spasticity associated pain with botulinum toxin A. , 2000, Journal of pain and symptom management.

[49]  L. Simpson.  CHAPTER 7 – Peripheral Actions of the Botulinum Toxins , 1989 .

[50]  K. Arimura,et al.  Extrafusal and intrafusal muscle effects in experimental botulinum toxin‐A injection , 1996, Muscle & nerve.

[51]  A. Thilmann,et al.  Biomechanical changes at the ankle joint after stroke. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[52]  Botulinum toxin in upper limb spasticity: study of reciprocal inhibition between forearm muscles , 1997, Neuroreport.

[53]  R. Schapiro.  Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis , 2001, Current neurology and neuroscience reports.

[54]  S. Andreassen,et al.  Non–reflex and reflex mediated ankle joint stiffness in multiple sclerosis patients with spasticity , 1993, Muscle & nerve.

[55]  B. Bhakta,et al.  Use of botulinum toxin in stroke patients with severe upper limb spasticity. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[56]  M. Maležič,et al.  Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[57]  R. Herman,et al.  The myotatic reflex. Clinico-physiological aspects of spasticity and contracture. , 1970, Brain : a journal of neurology.

[58]  Chronic transformation ofmuscle inspasticity: a peripheral contribution toincreased tone , 1985 .